LncRNA MIR4435‐2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR‐1224‐5p/TGFBR2 axis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LncRNA MIR4435‐2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR‐1224‐5p/TGFBR2 axis
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-04-22
DOI
10.1111/jcmm.15280
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond
- (2019) Anna M. Krichevsky et al. Neurotherapeutics
- Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
- (2019) Ulrich Herrlinger et al. LANCET
- The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression
- (2019) Weining Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma
- (2019) David J. Voce et al. CANCER RESEARCH
- The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a
- (2019) Qinglei Kong et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- The protean world of non-coding RNAs in glioblastoma
- (2019) Ramasamy Paulmurugan et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
- (2019) Jason Fangusaro et al. LANCET ONCOLOGY
- LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer
- (2019) Wen Ouyang et al. PeerJ
- The miR-371∼373 Cluster Represses Colon Cancer Initiation and Metastatic Colonization by Inhibiting the TGFBR2/ID1 Signaling Axis
- (2018) Pit Ullmann et al. CANCER RESEARCH
- Long Non-Coding RNA in Glioma: Target miRNA and Signaling Pathways
- (2018) Yuan Dang et al. Clinical Laboratory
- The lncRNA MIR4435-2HG promotes lung cancer progression by activating β-catenin signalling
- (2018) Haiyun Qian et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- LINC00152 Promotes Invasion Through a 3'-hairpin Structure and Associates with Prognosis in Glioblastoma
- (2018) Brian J. Reon et al. MOLECULAR CANCER RESEARCH
- LINC00470 Coordinates the Epigenetic Regulation of ELFN2 to Distract GBM Cell Autophagy
- (2018) Changhong Liu et al. MOLECULAR THERAPY
- WHO 2016 Classification of gliomas
- (2018) P. Wesseling et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway
- (2018) Bin Zhou et al. Cell Death & Disease
- Long Non-Coding RNAs in Gliomas: From Molecular Pathology to Diagnostic Biomarkers and Therapeutic Targets
- (2018) Marek Vecera et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Primary brain tumours in adults
- (2018) Sarah Lapointe et al. LANCET
- Non-Coding RNAs in Glioma
- (2018) Ryte Rynkeviciene et al. Cancers
- MicroRNA-520c inhibits glioma cell migration and invasion by the suppression of transforming growth factor-β receptor type 2
- (2017) Shengli Hu et al. ONCOLOGY REPORTS
- Comprehensive analysis of a novel four-lncRNA signature as a prognostic biomarker for human gastric cancer
- (2017) Yan Miao et al. Oncotarget
- The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer
- (2017) Dong Ke et al. Oncotarget
- MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-β pathway
- (2016) Xin He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2
- (2016) Furong Wei et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Survival in glioblastoma: a review on the impact of treatment modalities
- (2016) P. D. Delgado-López et al. Clinical & Translational Oncology
- Integrative Network Analysis Combined with Quantitative Phosphoproteomics Reveals Transforming Growth Factor-beta Receptor type-2 (TGFBR2) as a Novel Regulator of Glioblastoma Stem Cell Properties
- (2015) Yuta Narushima et al. MOLECULAR & CELLULAR PROTEOMICS
- MiR-1224-5p acts as a tumor suppressor by targeting CREB1 in malignant gliomas
- (2015) Jin Qian et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The Definition of Primary and Secondary Glioblastoma
- (2012) H. Ohgaki et al. CLINICAL CANCER RESEARCH
- MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF
- (2012) Neda Mosakhani et al. Cancer Genetics
- Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer
- (2011) Penny Nymark et al. GENES CHROMOSOMES & CANCER
- Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss
- (2011) Shelli M. Morris et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More